α-Glucosidase-IN-20
α-Glucosidase-IN-20 (Compound 3B) is a potent, orally active α-glucosidase inhibitor with an IC50 of 3.01 μM. α-Glucosidase-IN-20 shows anti-diabetic activity.
For research use only. We do not sell to patients.
- CAS No.: 420809-56-9
- Formula: C23H21NOS
- Molecular Weight:359.48
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
α-Glucosidase-IN-20 (10 and 20 mg/kg; p.o.; once) significantly decreases the serum glucose level after the administration of glucose (3 g/kg, oral) in rats[1].
α-Glucosidase-IN-20 (2000 mg/kg; p.o.; daily, for 2 weeks) demonstrates no mortality in mice[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Male Wistar albino rats (170-200 g), Streptozotocin-induced diabetes model[1]
-
Dosage:10 and 20 mg/kg
-
Administration:Oral administration; daily, for 4 weeks
-
Result:Decreased the level of blood glucose, reversed Streptozocin-induced body weight loss. Showed antihyperlipidemic effects on Streptozotocin-induced diabetes, reduced to a significant level of serum biomarkers.
Chemical Information
-
CAS No. 420809-56-9
-
Molecular Weight 359.48
-
Formula C23H21NOS
-
SMILES
COC1=CC=C(C=C1)C2CC(C3=CC=C(C=C3)C)=NC4=C(S2)C=CC=C4
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)